Stoke Therapeutics

STOKNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.111 B

$32.71 +2.44%

Close of 7 Aug 2026

Revenue

$184.4M

#2322 by revenue

Earnings

-$6.88M

Loss-making

Shares outstanding

64,526,242

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#108HUTCHMED (China)HCM$2.18B
#109Rapport TherapeuticsRAPP$2.18B
#110Stoke TherapeuticsSTOK$2.11B
#111GH ResearchGHRS$2.08B
#112Aurinia PharmaceuticalsAUPH$2.06B

Where these numbers come from

Share counts and financials for Stoke Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.